Replies to post #23461 on Cytodyn Inc (CYDY)

[finesand]

Misui- thank you

Yes, similar conclusion. Will try to find a 'data back up' of the CD01 extension screening enhancement.

Selection/screening and higher dosage (CCR5 Occupancy: CCR5 density, PRO 140 blood concentration) to be key here and shall resolve the desired predictability for trial and treatment success.

- CD03 high dosage arm reference added to blog.

Yes, lack of toxicity is one central pillar for PRO 140.